2,3-dihydroimidazo[1,2-c] pyrimidin-5(1H)-one compounds use as Lp-PLA2 inhibitors
- 专利权人:
- Glaxo Group Limited
- 发明人:
- Wan, Zehong,Long, Kai,Sang, Yingxia,Su, Xiaobo
- 申请号:
- AU2012289492
- 公开号:
- AU2012289492A1
- 申请日:
- 2012.07.25
- 申请国别(地区):
- AU
- 年份:
- 2014
- 代理人:
- 摘要:
- Disclosed are 2,3-dihydroimidazo[1,2-c]pyrimidin-5(1H)-one compounds that inhibit Lp-PLA
- 来源网站:
- 中国工程科技知识中心
相关发明人
相关专利
- Bicyclic pyrimidone compounds as inhibitors of Lp-PLA2
- 2,3-dihydroimidazol(1,2-c)pyrimidin-5(1h)-one based lipoprotein-associated phospholipase a2 (Lp-PLA2) inhibitors
- 2 3 DIHYDROIMIDAZOL[1 2 C]PYRIMIDIN 5(1H) ONE BASED LIPOPROTEIN ASSOCIATED PHOSPHOLIPASE A2 (LP PLA2) INHIBITORS
- 2,3-DIHYDROIMIDAZOL[1,2-C]PYRIMIDIN-5(1H)-ONE BASED LIPOPROTEIN-ASSOCIATED PHOSPHOLIPASE A2 (LP-PLA<;sb>;2<;/sb>;) INHIBITORS
- COMPOSÉS PYRIMIDONE UTILISÉS COMME INHIBITEURS DE LA LP-PLA2 ET COMPOSITIONS PHARMACEUTIQUES ASSOCIÉES